Following an infection, a subset of individuals can remain disease free despite harboring a pathogen for a prolonged period. In this issue of Cell, Sanchez et al. demonstrate that a metabolically favorable host response can drive an otherwise lethal bacterial pathogen to abandon virulence and become a commensal microorganism.
''If you really want to make a friend, go to someone's house and eat with him.'' -Caesar Chavez Host-pathogen interactions are typically viewed as a competition between defense pathways and countermeasures. This antagonistic relationship serves as the rationale behind conventional antimicrobial therapy that seeks to limit disease by reducing pathogen burden. However, a subset of infected individuals can harbor a deadly pathogen without developing disease-sometimes for prolonged periods of time. Thus, an infectious agent that is a pathogen in one individual can adopt a relationship in another individual that resembles commensalism, where the microbe benefits at no cost to the host. How such asymptomatic infections are established is poorly understood. In this issue of Cell, Sanchez et al. (2018) identify a novel mechanism in which a metabolically favorable environment in the host drives an enteric bacterial pathogen to forsake virulence to become a commensal.
To establish a model in which a subset of animals displays asymptomatic infection when challenged with a lethal pathogen, the authors orally inoculated susceptible C3H/HeJ mice with Citrobacter rodentium, a relative of E. coli. At lethal dose 50 (LD50), the number of bacteria that kills 50% of animals, the amount of Citrobacter shed in stool or found in extraintestinal tissue was indistinguishable between healthy mice and their counterparts that developed diarrheal disease and eventually died. Analysis of the liver transcriptome identified enhanced expression of genes involved in iron metabolism in the surviving mice, leading the authors to examine the effect of supplementing food with carbonyl iron, which is used to treat iron deficiency in humans. Remarkably, iron supplementation led to survival following infection, even with 1,000-fold higher numbers of bacteria than required for lethality ( Figure 1 ). This striking degree of protection was associated with a reduction in intestinal damage and extraintestinal dissemination of Citrobacter. Consistent with these findings, iron supplementation led to a decrease in transcriptional activity within the locus of enterocyte effacement (LEE), a bacterial pathogenicity island that encodes a type 3 secretion system and other virulence factors that mediate intestinal damage.
These results were initially surprising because iron is a micronutrient that is often limiting for bacterial pathogens and an important form of innate immunity (i.e., nutritional immunity) involves the sequestration of iron to starve the pathogen (Cassat and Skaar, 2013) . The authors found that dietary iron did not act directly on intestinal bacteria and instead inhibited the absorption of glucose in the gut, thereby increasing the availability of this sugar in the intestinal lumen (Figure 1 ). This increase in glucose reduced Citrobacter virulence gene expression, thus explaining the improved survival of mice receiving carbonyl iron.
The authors make a compelling argument that survival following Citrobacter infection is the result of a cooperative defense strategy by the host, where the goal is to alleviate disease by giving the pathogen what it wants. These exciting findings open many avenues for future research. Examining whether animals display differences in iron levels or other nutrients prior to Citrobacter infection can shed light on the source of heterogeneity and potentially reveal new methods to mitigate disease in vulnerable human populations such as hospital inpatients. Although the investigators rigorously examined the effect of carbonyl iron supplementation, the exact relationship between differential liver gene expression, iron metabolism, and glucose absorption remains unclear. Patients with iron overload are more susceptible to infection by a variety of enteric bacterial pathogens (Cassat and Skaar, 2013) . A detailed analysis of iron sequestration in tissue may prove to be useful. Increasing glucose availability through nutritional intervention also has complex consequences that trigger beneficial or harmful cellular responses depending on the pathogen (Wang et al., 2016) . The outcome of altering the iron-glucose axis revealed in this study is likely context dependent and requires additional investigation.
Given the similarities between Citrobacter and other members of the ubiquitous Enterobactericiae family of pathogens and commensals, it may be reasonable to speculate that some members of the gut microbiota are former pathogens that were domesticated through a similar cooperative defense strategy. Anorexia, fucosylation, mucus secretion, and production of lipocalins are all host responses that alter the metabolic environment of the gut in ways that favor colonization by commensal bacteria over pathogens (Deriu et al., 2013; Pickard et al., 2014; Ramanan and Cadwell, 2016) . When faced with such responses, some pathogens may have abandoned virulence to become commensal. However, the fitness cost of losing virulence may be too high in most instances. In other experimental settings, the LEE island is necessary for Citrobacter to counteract antimicrobial immunity at the epithelial barrier and compete with the microbiota for nutrients (Curtis et al., 2014; Kamada et al., 2012; Ramanan and Cadwell, 2016) , suggesting that the presence of better-adapted bacteria can deprive pathogens of the opportunity of becoming a commensal. Nevertheless, the right opportunity may present itself because the host environment does not remain constant. Alterations to the human microbiota caused by changes in human behavior, such as diet and hygiene, have been suggested to contribute to the rise in inflammatory diseases . This current study reminds us that virulence occurs on a continuum and that pro-inflammatory bacterial species may be evolutionary intermediates that are in the process of adapting to the new metabolic landscape of the modern human gut.
This concept that pathogens can permanently lose virulence under the right conditions is supported by the long-term effect of creating a metabolically favorable environment for Citrobacter. After removing carbonyl iron from the chow, mice remained persistently infected for months without displaying disease, indicating that a new equilibrium was reached between host and pathogen. Citrobacter strains isolated from these iron-fed mice harbored mutations in virulence genes and were non-lethal when introduced into a new host. Virulence strategies generally come at a cost for the pathogen. In the case of Citrobacter, virulence factors encoded within the LEE island are targeted by antibodies, providing selective pressure for these genes to be repressed (Kamada et al., 2015) . Jettisoning virulence factors that are a burden when nutrients are abundant may be a common outcome for pathogens. After all, why bite the hand that feeds you? Comparison of healthy and dying mice inoculated with a lethal dose 50 (LD50) of the bacterial pathogen Citrobacter rodentium revealed differences in the liver transcriptome, where mice that survived displayed enhanced expression of iron metabolism genes. Iron supplementation enhanced survival by decreasing glucose absorption in the intestine, which increased the availability of glucose in the intestinal lumen. In the presence of abundant glucose, Citrobacter repressed the expression of virulence genes, leading to a mutually beneficial outcome consisting of an asymptomatic and persistent infection. Citrobacter isolated from iron-fed mice were avirulent when transferred into a naive animal, providing a remarkable example of how a pathogen can be tamed by a favorable metabolic environment in the host to become a commensal microorganism.
